FACULTY
Understanding the Ramifications of Switching Among AEDs: A 2008 Clinical Update
The contents of this issue of University of Tennessee Advanced Studies in Pharmacy include 3 review articles and a roundtable discussion.
Activity Date: July 2008  — Activity Info: Volume 5, (5)
Goals & Objectives | Faculty | Complete Pre-Test Activity | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired)

 

Full Disclosure Policy Affecting CE Activities:
As a sponsor accredited by the Accreditation Council for Pharmacy Education (ACPE), it is the policy of the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Course Directors and Participating Faculty reported the following:

COURSE DIRECTORS

Adam L. Hartman, MD
Assistant Professor of Neurology and Pediatrics
John M. Freeman Pediatric Epilepsy Center
Department of Neurology
The Johns Hopkins Medical Institutions
Baltimore, Maryland
Dr Hartman reports having no financial or advisory relationships with corporate organizations related to this activity.

Stephanie J. Phelps, PharmD, BCPS
Professor, Clinical Pharmacy and Pediatrics
The University of Tennessee Health Science Center
Memphis, Tennessee
Dr Phelps reports receiving grants/research support and serving as a consultant for GlaxoSmithKline.

Eileen P. Vining, MD
Professor of Neurology and Pediatrics
Director of the John M. Freeman Pediatric Epilepsy Center
Department of Neurology
The Johns Hopkins Medical Institutions
Baltimore, Maryland
Dr Vining reports having no financial or advisory relationships with corporate organizations related to this activity.

PARTICIPATING FACULTY

Gail D. Anderson, PhD
Professor
Department of Pharmacy
University of Washington
Seattle, Washington
Dr Anderson reports having no financial or advisory relationships with corporate organizations related to this activity.

Michel J. Berg, MD
Associate Professor of Neurology
Medical Director, Strong Epilepsy Center
Department of Neurology
University of Rochester Medical Center
Rochester, New York
Dr Berg reports serving as a consultant for Harris Interactive through a grant from GlaxoSmithKline.

William R. Garnett, PharmD
Professor of Pharmacy and Neurology
Virginia Commonwealth University
Medical College of Virginia
School of Pharmacy
Richmond, Virginia
Dr Garnett reports receiving grants/research support from Ovation; receiving honoraria from R&R Health Communications; and serving on the speakers’ bureau for Abbott Laboratories and UCB Pharma.

Notice: The audience is advised that articles in this CE activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Dr Garnett—possible mention of off-label drugs.
Dr Hartman—may discuss pediatric uses for antiepileptic drugs.
Dr Phelps— many antiepileptic drugs are off-label in children and may be discussed.
Dr Vining—many antiepileptic drugs are off-label in children.

All other faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or devices.

University of Tennessee Advanced Studies in Pharmacy provides disclosure information from contributing authors, lead presenters, and participating faculty. University of Tennessee Advanced Studies in Pharmacy does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?